FTC sues insulin middlemen, saying they pocket billions while patients face high costs
- Posted on September 21, 2024
- By NPR
- 1 Views
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
